|
1
|
Kusamura S, Baratti D, Zaffaroni N, Villa
R, Laterza B, Balestra MR and Deraco M: Pathophysiology and biology
of peritoneal carcinomatosis. World J Gastrointest Oncol. 2:12–18.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Muñoz-Casares FC, Rufián S, Arjona-Sánchez
Á, Rubio MJ, Díaz R, Casado Á, Naranjo Á, Díaz-Iglesias CJ, Ortega
R, Muñoz-Villanueva MC, et al: Neoadjuvant intraperitoneal
chemotherapy with paclitaxel for the radical surgical treatment of
peritoneal carcinomatosis in ovarian cancer: A prospective pilot
study. Cancer Chemother Pharmacol. 68:267–274. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guardiola E, Delroeux D, Heyd B, Combe M,
Lorgis V, Demarchi M, Stein U, Royer B, Chauffert B and Pivot X:
Intra-operative intra-peritoneal chemotherapy with cisplatin in
patients with peritoneal carcinomatosis of ovarian cancer. World J
Surg Oncol. 7:142009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Macrì A, Saladino E, Bartolo V, Adamo V,
Altavilla G, Mondello E, Condemi G, Sinardi A and Famulari C:
Peritoneal carcinomatosis of colorectal origin. World J
Gastrointest Oncol. 2:98–101. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sadeghi B, Arvieux C, Glehen O, Beaujard
AC, Rivoire M, Baulieux J, Fontaumard E, Brachet A, Caillot JL,
Faure JL, et al: Peritoneal carcinomatosis from non-gynecologic
malignancies: Results of the EVOCAPE 1 multicentric prospective
study. Cancer. 88:358–363. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yan TD, Stuart OA, Yoo D and Sugarbaker
PH: Perioperative intraperitoneal chemotherapy for peritoneal
surface malignancy. J Transl Med. 4:172006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Davy M, Mossige J and Johannessen JV:
Heterologous growth of human ovarian cancer. A new in vivo testing
system. Acta Obstet Gynecol Scand. 56:55–59. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mei LJ, Yang XJ, Tang L, Hassan AH,
Yonemura Y and Li Y: Establishment and identification of a rabbit
model of peritoneal carcinomatosis from gastric cancer. BMC Cancer.
10:1242010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Massazza G, Tomasoni A, Lucchini V,
Allavena P, Erba E, Colombo N, Mantovani A, D'Incalci M, Mangioni C
and Giavazzi R: Intraperitoneal and subcutaneous xenografts of
human ovarian carcinoma in nude mice and their potential in
experimental therapy. Int J Cancer. 44:494–500. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ward BG, Wallace K, Shepherd JH and
Balkwill FR: Intraperitoneal xenografts of human epithelial ovarian
cancer in nude mice. Cancer Res. 47:2662–2667. 1987.PubMed/NCBI
|
|
11
|
Fidler IJ: Critical factors in the biology
of human cancer metastasis: Twenty-eighth G.H.A. Clowes memorial
award lecture. Cancer Res. 50:6130–6138. 1990.PubMed/NCBI
|
|
12
|
Santoro L, Boutaleb S, Garambois V,
Bascoul-Mollevi C, Boudousq V, Kotzki PO, Pèlegrin M,
Navarro-Teulon I, Pèlegrin A and Pouget JP: Noninternalizing
monoclonal antibodies are suitable candidates for 125I
radioimmunotherapy of small-volume peritoneal carcinomatosis. J
Nucl Med. 50:2033–2041. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu Y, Silver DF, Yang NP, Oflazoglu E,
Hempling RE, Piver MS and Repasky EA: Characterization of human
ovarian carcinomas in a SCID mouse model. Gynecol Oncol.
72:161–170. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhong L, Roybal J, Chaerkady R, Zhang W,
Choi K, Alvarez CA, Tran H, Creighton CJ, Yan S, Strieter RM, et
al: Identification of secreted proteins that mediate cell-cell
interactions in an in vitro model of the lung cancer
microenvironment. Cancer Res. 68:7237–7245. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gout S and Huot J: Role of cancer
microenvironment in metastasis: Focus on colon cancer. Cancer
Microenviron. 1:69–83. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fidler IJ, Kim SJ and Langley RR: The role
of the organ microenvironment in the biology and therapy of cancer
metastasis. J Cell Biochem. 101:927–936. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu X and Prestwich GD: Inhibition of tumor
growth and angiogenesis by a lysophosphatidic acid antagonist in an
engineered three-dimensional lung cancer xenograft model. Cancer.
116:1739–1750. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nicosia RF and Ottinetti A: Modulation of
microvascular growth and morphogenesis by reconstituted basement
membrane gel in three-dimensional cultures of rat aorta: A
comparative study of angiogenesis in matrigel, collagen, fibrin and
plasma clot. Vitro Cell Dev Biol. 26:119–128. 1990. View Article : Google Scholar
|
|
19
|
Kleinman HK and Martin GR: Matrigel:
Basement membrane matrix with biological activity. Semin Cancer
Biol. 15:378–386. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Carey DJ, Todd MS and Rafferty CM: Schwann
cell myelination: Induction by exogenous basement membrane-like
extracellular matrix. J Cell Biol. 102:2254–2263. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Akbasak A, Toevs CC and Laske DW:
Reconstituted basement membrane (matrigel) enhances the growth of
human glioma cell lines in nude mice. J Neurooncol. 27:23–30. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ishii E, Greaves A, Grunberger T, Freedman
MH and Letarte M: Tumor formation by a human pre-B leukemia cell
line in scid mice is enhanced by matrigel and is associated with
induction of CD10 expression. Leukemia. 9:175–184. 1995.PubMed/NCBI
|
|
23
|
Wang X, Duan X, Yang G, Zhang X, Deng L,
Zheng H, Deng C, Wen J, Wang N, Peng C, et al: Honokiol Crosses BBB
and BCSFB and inhibits brain tumor growth in rat 9L intracerebral
gliosarcoma model and human U251 xenograft glioma model. PLoS One.
6:e184902011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sumitomo M, Koizumi F, Asano T, Horiguchi
A, Ito K, Asano T, Kakizoe T, Hayakawa M and Matsumura Y: Novel
SN-38-incorporated polymeric micelle, NK012, strongly suppresses
renal cancer progression. Cancer Res. 68:1631–1635. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nagano T, Yasunaga M, Goto K, Kenmotsu H,
Koga Y, Kuroda J, Nishimura Y, Sugino T, Nishiwaki Y and Matsumura
Y: Synergistic antitumor activity of the SN-38-incorporating
polymeric micelles NK012 with S-1 in a mouse model of non-small
cell lung cancer. Int J Cancer. 127:2699–2706. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Micames C, Jowell PS, White R, Paulson E,
Nelson R, Morse M, Hurwitz H, Pappas T, Tyler D and McGrath K:
Lower frequency of peritoneal carcinomatosis in patients with
pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA.
Gastrointest Endosc. 58:690–695. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sasiak AB, Sebesteny A, Hrivnak G and
Lloyd DH: Experimental dermatophilosis in murine models of
immunodeficiency. Rev Elev Med Vet Pays Trop. 46:263–269.
1993.PubMed/NCBI
|
|
28
|
Zeng QL, Chu ZH, Zhou K and Luo XJ: Effect
of Endostatin and SU6668 combined with 5-FU on human colon cancer
xenograft in nude mice. Zhonghua Wei Chang Wai Ke Za Zhi.
11:376–378. 2008.(In Chinese). PubMed/NCBI
|
|
29
|
Frisk T, Rydholm S, Andersson H, Stemme G
and Brismar H: A concept for miniaturized 3-D cell culture using an
extracellular matrix gel. Electrophoresis. 26:4751–4758. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Engbring JA and Kleinman HK: The basement
membrane matrix in malignancy. J Pathol. 200:465–470. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kleinman HK, Philp D and Hoffman MP: Role
of the extracellular matrix in morphogenesis. Curr Opin Biotechnol.
14:526–532. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ponce ML, Nomizu M, Delgado MC, Kuratomi
Y, Hoffman MP, Powell S, Yamada Y, Kleinman HK and Malinda KM:
Identification of endothelial cell binding sites on the laminin
gamma 1 chain. Circ Res. 84:688–694. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang Y, Gong C, Yang L, Wu Q, Shi S, Shi
H, Qian Z and Wei Y: 5-FU-hydrogel inhibits colorectal peritoneal
carcinomatosis and tumor growth in mice. BMC Cancer. 10:4022010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yu L, Wang Y, Yao Y, Li W, Lai Q, Li J,
Zhou Y and Kang T: Eradication of growth of HER2-positive ovarian
cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate
in mouse xenograft model. Int J Gynecol Cancer. 24:1158–1164. 2014.
View Article : Google Scholar : PubMed/NCBI
|
